How to Get a GLP-1 Prescription in 2026: Easier Than You Think

Here's a number that should stop you in your tracks: according to FAIR Health data, more than 80% of Americans with an overweight or obesity diagnosis have never received a GLP-1 prescription, bariatric surgery referral, or behavioral health service for weight management. Eight out of ten people who medically qualify are getting nothing.

And yet the drugs work. GLP-1 medications produce 15-21% body weight loss in clinical trials — results so dramatic that bariatric surgery rates dropped 41.8% between 2019 and 2024 as prescriptions surged. A 2026 RAND survey found that nearly 12% of American adults — roughly 1 in 8 — have already used a GLP-1 medication. The PRC National Health Survey puts the number of current users at more than 1 in 10 adults.

The gap between "could benefit" and "actually prescribed" is closing fast. GLP-1 prescriptions grew 15% in just the first quarter of 2026, and first-time prescriptions for weight-loss semaglutide jumped more than 50% in that same period. If you've been thinking about it but haven't taken the step, this guide is for you.

Do you qualify? (You probably do)

The eligibility criteria for GLP-1 medication are broader than most people realize. You likely qualify if you meet either of two conditions.

That's it. Those two criteria cover approximately 42% of American adults — roughly 110 million people. Many people assume they "aren't heavy enough" or "don't have a serious enough condition" to qualify. In reality, the threshold is lower than expected, and the list of qualifying comorbidities has expanded significantly. In 2026, cardiovascular risk reduction alone is a qualifying indication for Wegovy, meaning patients with heart disease history can access the medication regardless of their weight-loss goals.

The four paths to a GLP-1 prescription

Path 1: Telehealth — fastest and most popular

Telehealth now accounts for a significant share of all GLP-1 prescriptions. Eli Lilly reported that 35% of Foundayo's initial prescriptions in April 2026 came through telehealth platforms. The process is straightforward.

The best telehealth providers for GLP-1 prescriptions combine speed, clinical quality, and transparent pricing.

Path 2: Your primary care doctor

You don't need a specialist. Any licensed physician, nurse practitioner, or physician assistant can prescribe GLP-1 medications. If you already have a primary care provider, this may be the easiest path — you have an established medical relationship, your health records are on file, and the conversation can happen during a routine visit. Bring up GLP-1 medication directly. Many doctors are receptive but won't initiate the conversation themselves. A simple approach: "I've been reading about GLP-1 medications for weight management and I'd like to discuss whether I'm a candidate."

Path 3: Brand-name through insurance

If your insurance covers GLP-1 medication, the out-of-pocket cost can drop to as low as $25 per month with manufacturer savings cards. A provider like Sesame Care (Paid link) specializes in navigating insurance coverage, prior authorization, and manufacturer savings programs for brand-name Wegovy, Ozempic, Zepbound, and Foundayo. The tradeoff: prior authorization can add days or weeks to the process, and denial rates at major insurers range from 4% to nearly 13%.

Path 4: Medicare (starting July 1, 2026)

The Medicare GLP-1 Bridge program launches July 1, offering brand-name medications at $50 per month for eligible Part D beneficiaries. If you're on Medicare, this will be the most affordable GLP-1 access available anywhere. Eligibility requires BMI 30+ (or 27+ with a qualifying comorbidity) and a prescriber's determination that GLP-1 treatment is medically appropriate.

Do you need lab work? (Usually not)

This is one of the most common barriers that stops people from starting — the assumption that they'll need blood tests, fasting panels, or other lab work before getting a prescription. The reality: most telehealth providers do not require lab work before prescribing GLP-1 medication. Your health questionnaire, reported medical history, and stated weight/height are typically sufficient for initial prescribing.

Some providers request labs after starting treatment — particularly A1C and metabolic panels at 3-6 month intervals — to monitor your response. But this is follow-up monitoring, not a barrier to starting. If a provider requires extensive upfront lab work before they'll consider prescribing, that's unusual in the current telehealth landscape and may indicate an unnecessarily bureaucratic process.

What about the needle?

In 2026, needles are optional. Two FDA-approved oral GLP-1 medications are now available for weight management. Oral Wegovy (semaglutide tablets) launched in December 2025, and Foundayo (orforglipron) received FDA approval on April 1, 2026. Foundayo is the simpler option: take it any time of day, with or without food, no water restrictions. Oral Wegovy requires an empty stomach and a 30-minute wait before eating.

Brand-name oral GLP-1 starts at $149 per month for self-pay patients. For compounded oral options, FeelGood Telehealth (Paid link) offers oral compounded tablets from $249/month alongside injectable options.

That said, the weekly injection is less daunting than most people expect. The needle is tiny — 4-5mm, thinner than a standard sewing needle — and the injection takes about 5 seconds. Most patients report that the anticipation is far worse than the reality.

What it costs in June 2026

Prices verified June 2026. Compounded medications are not FDA-approved.

The number that matters most

Eli Lilly's CEO put it plainly when Foundayo launched: "Fewer than 1 in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity, or the belief that their condition isn't serious enough for treatment." That last part — "the belief that their condition isn't serious enough" — is the barrier this article exists to break down.

Obesity is a chronic medical condition with FDA-approved treatments. Getting a prescription is a 10-minute telehealth conversation, not a months-long clinical gauntlet. The medication can arrive in days, not weeks. And the costs have dropped to levels that would have been inconceivable two years ago.

If you've been thinking about it, the best time to start was yesterday. The second best time is right now.